Market Tracker

12/19 6:43am ET

Novavax Inc (NASDAQ:NVAX)

5.92
Data as of Dec 18
 +0.01 / +0.17%
Today’s Change
3.34
Today|||52-Week Range
6.95
+15.62%
Year-to-Date
Forget Calling a Bottom
Dec 15 / TheStreet.com
A Slow Drift Downward
Dec 15 / TheStreet.com
Oil Issues Are Normalizing the Market
Dec 15 / TheStreet.com
 

Today’s Trading

Previous close5.91
Today’s open6.01
Day’s range-- - --
Volume3,391,798
Average volume (3 months)4,026,246
Market cap$1.4B
Dividend yield--
Data as of 12/18/2014

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)-0.72%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book6.07

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+0.08+0.17%
RLYPRelypsa Inc-0.47-1.46%
HALOHalozyme Therapeutic...+0.37+4.28%
RDUSRadius Health Inc+0.59+1.91%
Data as of 12/18/2014

Financials

Next reporting dateMarch 30, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts